Ross Kenneth Urken is editor of MainStreet and personal finance editor at TheStreet. He has published in The New York Times, The Wall Street Journal, The Washington Post, New York, The New Republic, The Atlantic, VICE, Tablet, Slate, TENNIS Magazine, The Paris Review, The Moscow Times, Forbes, Nautilus, National Geographic, and Newsweek. He previously worked at AOL and appears widely on television and radio. He is a graduate of Princeton University, where he studied comparative literature. For more information visit rosskennethurken.com
Recent Articles By The Author
How to Invest in a Racehorse Even If You're Not a Millionaire
For those looking to diversify their portfolio while potentially giving their money a little giddy-up, investing in thoroughbreds is an exciting avenue to take, despite the risks.
Ford Uses FordPass to Develop as a Tech Company, Not Just an Automaker
Automotive companies like Ford can no longer idle as simple car manufacturers; they also have to be technology-focused, full-service mobility providers. Enter FordPass.
Ford Looks to Establish Itself as a Tech Company, Not Just an Automaker
Ford can no longer idle as simple car manufacturers; they also have to be technology-focused, full-service mobility providers that can deliver on services like entertainment, smart parking and commercial partnerships.
10 Sexy Updates to Speedy Classics at the New York Auto Show
At the 2016 New York International Auto Show, you'll notice a clear theme take form: futuristic updates on heritage classics.
GWPH Momentum Passed Around to Other Pot Stocks
GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.